报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 2.55% | -68.01% | 51.79% | 92/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 1.68% | -68.48% | 48.67% | 91/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 1.13% | -69.95% | -87.43% | 91/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 8.99% | -42% | 12.8% | 34/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 7.97% | -45.41% | 49.53% | 40/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 5.33% | -38.67% | 41.76% | 40/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 3.76% | -22.47% | -75.74% | 21/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 15.5% | -6.34% | 6.16% | 17/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 14.6% | -3.95% | 68.01% | 12/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 8.69% | 0.35% | 79.18% | 20/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 4.85% | 17.72% | -70.69% | 15/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 16.55% | -10.83% | 8.88% | 19/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 15.2% | -15.88% | 75.52% | 13/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 8.66% | -20.04% | 110.19% | 20/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 4.12% | -9.05% | -77.8% | 20/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 18.56% | -33.57% | 2.71% | 23/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-09-30 | 18.07% | 2% | 66.85% | 9/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
2020-06-30 | 10.83% | 0.74% | 139.07% | 15/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
2020-03-31 | 4.53% | 2% | -83.79% | 16/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
2019-12-31 | 27.94% | 21.58% | 159.91% | 8/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
2019-06-30 | 10.75% | 2% | -53.22% | 13/160 | 5.05% | 奥赛康 | 35% | 行业排名> |
2018-12-31 | 22.98% | 44.26% | 44.26% | 9/160 | 7.09% | 奥赛康 | 28.15% | 行业排名> |
2017-12-31 | 15.93% | -10.51% | -10.51% | 21/160 | 9.66% | 宏源药业 | 21.91% | 行业排名> |
2016-12-31 | 17.8% | 2% | 2% | 29/160 | 6.33% | 奥赛康 | 9.7% | 行业排名> |